BIODESIX INC (BDSX)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenues | 20,018 | 17,958 | 18,151 | |
| Sales, marketing, general and administrative | 22,411 | 20,448 | 20,016 | |
| Research and development | 3,269 | 2,870 | 2,547 | |
| Impairment loss on intangible assets | 26 | 73 | - | |
| Direct costs and expenses | 4,031 | 3,703 | 4,179 | |
| Total operating expenses | 29,737 | 27,094 | 26,742 | |
| Loss from operations | -9,719 | -9,136 | -8,591 | |
| Other income (expense), net | 51 | 98 | 374 | |
| Interest expense | 1,898 | 1,685 | 2,041 | |
| Change in fair value of warrant liability, net | -98 | 378 | - | |
| Total other expense | -1,749 | -1,965 | -1,667 | |
| Net loss | -11,468 | -11,101 | -10,258 | |
| Earnings per share, basic, total | -0.08 | -0.08 | -0.07 | |
| Earnings per share, diluted, total | -0.08 | -0.08 | -0.07 | |
| Weighted average number of shares outstanding, basic, total | 146,656,000 | 146,547,000 | 146,296,000 | |
| Weighted average number of shares outstanding, diluted, total | 146,656,000 | 146,547,000 | 146,296,000 | |